Loading...
Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
BACKGROUND: Schizophrenia is a highly heterogeneous disorder, and around a third of patients are treatment-resistant. The only evidence-based treatment for these patients is clozapine, an atypical antipsychotic with relatively weak dopamine antagonism. It is plausible that varying degrees of respons...
Saved in:
| Published in: | BMC Psychiatry |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5237235/ https://ncbi.nlm.nih.gov/pubmed/28086761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-016-1177-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|